Adverum Biotechnologies (ADVM) Misses Q3 EPS by 1c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q3 EPS of ($0.33), $0.01 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
• Worried the AI trade has gone too far? Evercore likes these 4 stocks